Inner_G84 | 20 points
Mountain Valley MD interview conversation on plans with their enhanced delivery technology of Ivermectin. BSL-4 testing soon to start and more...[-] hanstoppable | 3 points
According to https://ivmmeta.com/, the use of Ivermectin is showing improvement at 52% for the 'Late Treatment' phase.
By having a solution of Ivermectin that has 1) greater solubility and injectability, 2) faster onset, and 3) lower variability could potentially help improve that percentage specifically for the Late-Treatment phase.
I am not a scientist by any means but that is where I could suspect MVMD could be particularly relevant if Ivermectin gets widely adopted.
[-] CodeNamedG | 2 points
Another interview with more details released today.
https://youtu.be/XpDJDSfzorQ
[-] Admirable-Raise9185 | 1 points
WHY? You can purchase Ivermectin now worldwide and take it. Why wait and spend much more than the 3 mg, 6 mg and 12 mg pills already available.
If I'm a manufacturer and a company has tech that can make my final product use 1/8 less ingredients I would be interested.
[-] Admirable-Raise9185 | 5 points
Remember they have patents and that is the reason it will be manufactured and marked for a lot more money. The drug cost is pennies to manufacture in India, it is generic and OTC in most markets without a Rx require.
There is a concern of supply going short if there is true worldwide adoption of ivermectin. What this company is developing is a way to bypass the pill because swallowing a pill wastes 80% of the material just to get it into your bloodstream (via ingestion). With their tech, it'll be possible to use just the 20% needed and have it go directly where it's needed faster (minutes vs hours earlier).
[-] Admirable-Raise9185 | 2 points
True, but at what cost? Almost 4 billion dosea are given worldwide now. Just scale up manufacturing. Changing the drug delivery just will increase cost very significantly and delays heard immunity now.
[-] WealthOnAShelf | 2 points
They are making major improvements to dose size and efficiency of Ivermectin. It will disrupt and eventually replace the tablet form. But for now, sure, ramp up production of the tablets. It’s saving lives...it’s a no brainer
[-] Haitchpeasauce | 2 points
India seemed to have had no problems supplying their population. Supply issues worldwide are only because the world stubbornly denied the importance of this drug for far too long. Concerns over effective plasma concentration are so overblown all traced back to the one study out of Monash.
The oral form works just fine.
This just looks like another attempt to profiteer using contrived reasons.
Make the pills, use the pills, get on with it.
[-] ResponsibilityAny555 | 3 points | Feb 22 2021 01:11:43
They are confirming the results of their technology in the lab for Quicker ivermectin onset and larger bioavailability in the body versus the oral route. If the independent lab results show the effects that they believe they have for ivermectin delivery, why would anyone not want to take a more effective treatment option then just saying YOLO and self dosing?
permalink
[-] ChrAlbert | 3 points | Feb 22 2021 20:43:59
As I see it, the product of MVMD is not ivermectin but it is the coating of this substance. If they are successful in coating ivermectin they can as well be similarly successful with other drugs with acritical bioavailability. In my point of view, this is as important as the technique of m-RNA is essential to future applications for example as a cure to cancer. If you can use the technique for one drug, you can use it for many drugs. Spoken from the standpoint of quicksome technology as well as m-RNA-technology COVID was a blessing, because public interest in these techniques developed far faster than it would’ve been possible under normal circumstances.
permalink